Facebook
Twitter
Telegram
Report an ErrorInterpace Biosciences Balance Sheet 2011-2024 | IDXG
Annual Balance Sheet Interpace Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-1.65 M | -2.4 M | -1.39 M | 1.97 M | 4.78 M | -6.07 M | -15.2 M | 7.31 M | 87 K | 4.15 M | -45.6 M | -52.8 M | -64.3 M |
Long Term Debt |
1.47 M | 1.85 M | 520 K | - | 3 M | - | - | 7.91 M | 7.23 M | 27.2 M | - | - | - |
Long Term Debt Current |
377 K | 578 K | 762 K | 1.03 M | - | - | - | - | 1.16 M | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 10 M | 38.7 M | 7.01 M | 5.64 M | 19 M | 31.3 M | 62.2 M | 5.18 M | 6.43 M | 7.78 M |
Total Current Liabilities |
17.5 M | 14.3 M | 15.7 M | 18.2 M | 17.3 M | 8.49 M | 8.09 M | 16.2 M | 23.4 M | 33.6 M | 31.4 M | 36.4 M | 46.1 M |
Total Liabilities |
28.2 M | 32.5 M | 34.3 M | 28.2 M | 56 M | 15.5 M | 13.7 M | 35.2 M | 54.7 M | 95.8 M | 36.6 M | 42.8 M | 53.9 M |
Deferred Revenue |
- | - | - | 54 K | 457 K | - | - | - | - | 6.75 M | 9.38 M | 14.5 M | 15.9 M |
Retained Earnings |
-248 M | -249 M | -227 M | -212 M | -168 M | -141 M | -132 M | -120 M | -111 M | -99.9 M | -83.8 M | -79.3 M | -53.7 M |
Total Assets |
13 M | 16 M | 38.4 M | 45.7 M | 69.1 M | 48.4 M | 53.6 M | 41.8 M | 67.7 M | 116 M | 69.1 M | 78.4 M | 113 M |
Cash and Cash Equivalents |
3.5 M | 4.83 M | 2.67 M | 2.77 M | 2.32 M | 6.07 M | 15.2 M | 602 K | 8.31 M | 23.1 M | 45.6 M | 52.8 M | 64.3 M |
Book Value |
-15.1 M | -16.5 M | 4.12 M | 17.5 M | 13 M | 32.9 M | 39.9 M | 6.53 M | 13 M | 20.1 M | 32.5 M | 35.6 M | 59.5 M |
Total Shareholders Equity |
-61.7 M | -63.1 M | -42.4 M | -29.1 M | -4.48 M | 15.4 M | 39.9 M | 39.9 M | 13 M | 20.1 M | 32.5 M | 35.6 M | 59.5 M |
All numbers in USD currency
Quarterly Balance Sheet Interpace Biosciences
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
1.36 M | 1.47 M | 1.56 M | 1.65 M | 1.75 M | 1.85 M | 184 K | 2.72 M | 2.97 M | 520 K | 3.23 M | 3.2 M | 3.44 M | 3.68 M | 3.78 M | 3.68 M | 1.47 M | 2.71 M | 2.96 M | 2.59 M | 2.59 M | - | - | - | - | - | - | - | 4.36 M | 7.91 M | 7.91 M | 7.91 M | 7.91 M | 7.23 M | 7.23 M | 7.23 M | 7.23 M | 27.2 M | 27.2 M | 27.2 M | 27.2 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.56 M | 4.57 M | - | - | 4.25 M | 4.32 M | 4.73 M | 4.34 M | 4.32 M | 4.29 M | 4.29 M | 4.29 M | 4.29 M | - | - | 4.71 M | 4.7 M | 6.18 M | 8.08 M | 8.74 M | 6.18 M | 8.81 M | 9.14 M | 9.14 M | 9.14 M | 5.18 M | 5.18 M | 5.18 M | 5.18 M | 6.43 M | 6.43 M | 6.43 M | 6.43 M | 7.78 M | 7.78 M | 7.78 M | 7.78 M |
Total Liabilities |
26.7 M | 28.2 M | 30.4 M | 31.6 M | 31.9 M | 32.5 M | 30.4 M | 36.9 M | 36.2 M | 34.3 M | 32.4 M | 32.4 M | 30.2 M | 28.2 M | 28.2 M | 28.2 M | 28.2 M | 29.8 M | 29.8 M | 29.8 M | 29.8 M | 15.7 M | 15.5 M | 15.5 M | 15.5 M | 13.7 M | 13.7 M | 13.7 M | 13.7 M | 35.2 M | 35.2 M | 35.2 M | 35.2 M | 54.7 M | 54.7 M | 54.7 M | 54.7 M | 95.8 M | 95.8 M | 95.8 M | 95.8 M | 36.6 M | 36.6 M | 36.6 M | 36.6 M | 42.8 M | 42.8 M | 42.8 M | 42.8 M | 53.9 M | 53.9 M | 53.9 M | 53.9 M |
Deferred Revenue |
- | - | - | - | - | - | - | 18 K | 31 K | 40 K | 40 K | 43 K | 52 K | 54 K | 54 K | 54 K | 54 K | 457 K | 457 K | 457 K | 457 K | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.11 M | 6.87 M | 10.9 M | 6.75 M | 7.61 M | 6.75 M | 6.75 M | 7.35 M | 9.38 M | 9.38 M | 9.38 M | 14.5 M | 14.5 M | 14.5 M | 14.5 M | 15.9 M | 15.9 M | 15.9 M | 15.9 M |
Retained Earnings |
-248 M | -248 M | -249 M | -248 M | -249 M | -249 M | -247 M | -233 M | -229 M | -227 M | -223 M | -220 M | -216 M | -212 M | -212 M | -212 M | -212 M | -186 M | -186 M | -186 M | -186 M | -159 M | -141 M | -141 M | -141 M | -132 M | -132 M | -132 M | -132 M | -120 M | -120 M | -120 M | -120 M | -111 M | -111 M | -111 M | -111 M | -99.9 M | -99.9 M | -99.9 M | -99.9 M | -83.8 M | -83.8 M | -83.8 M | -83.8 M | -79.3 M | -79.3 M | -79.3 M | -79.3 M | -53.7 M | -53.7 M | -53.7 M | -53.7 M |
Total Assets |
12.1 M | 13 M | 14.2 M | 15.9 M | 15.9 M | 16 M | 15.3 M | 35.5 M | 38.4 M | 38.4 M | 40.3 M | 43.2 M | 43.9 M | 45.7 M | 45.7 M | 45.7 M | 45.7 M | 51.5 M | 51.5 M | 51.5 M | 51.5 M | 31.1 M | 48.4 M | 48.4 M | 48.4 M | 36.6 M | 53.6 M | 53.6 M | 53.6 M | 25.1 M | 41.8 M | 41.8 M | 41.8 M | 64.7 M | 67.7 M | 67.7 M | 67.7 M | 115 M | 116 M | 116 M | 116 M | 69.1 M | 69.1 M | 69.1 M | 69.1 M | 78.4 M | 78.4 M | 78.4 M | 78.4 M | 113 M | 113 M | 113 M | 113 M |
Cash and Cash Equivalents |
2.81 M | 3.5 M | 5.03 M | 5.08 M | 5.6 M | 4.83 M | 6.31 M | 2.12 M | 3.1 M | 2.67 M | 3.43 M | 3.79 M | 2.84 M | 2.77 M | 2.77 M | 2.77 M | 2.77 M | 2.32 M | 2.32 M | 2.32 M | 2.32 M | 6.07 M | 6.07 M | 6.07 M | 6.07 M | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 602 K | 602 K | 602 K | 602 K | 8.31 M | 8.31 M | 8.31 M | 8.31 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 45.6 M | 45.6 M | 45.6 M | 45.6 M | 52.8 M | 52.8 M | 52.8 M | 52.8 M | 64.3 M | 64.3 M | 64.3 M | 64.3 M |
Book Value |
-14.6 M | -15.1 M | -16.1 M | -15.7 M | -16 M | -16.5 M | -15.1 M | -1.42 M | 2.2 M | 4.12 M | 7.89 M | 10.7 M | 13.6 M | 17.5 M | 17.5 M | 17.5 M | 17.5 M | 21.7 M | 21.7 M | 21.7 M | 21.7 M | 15.4 M | 32.9 M | 32.9 M | 32.9 M | 22.9 M | 39.9 M | 39.9 M | 39.9 M | -10.1 M | 6.53 M | 6.53 M | 6.53 M | 10.1 M | 13 M | 13 M | 13 M | 19.4 M | 20.1 M | 20.1 M | 20.1 M | 32.5 M | 32.5 M | 32.5 M | 32.5 M | 35.6 M | 35.6 M | 35.6 M | 35.6 M | 59.5 M | 59.5 M | 59.5 M | 59.5 M |
Total Shareholders Equity |
-61.1 M | -61.7 M | -62.7 M | -62.2 M | -62.5 M | -63.1 M | -61.6 M | -48 M | -44.3 M | -42.4 M | -38.6 M | -35.8 M | -32.9 M | -29.1 M | -29.1 M | -29.1 M | -29.1 M | -4.48 M | -4.48 M | -4.48 M | -4.48 M | 15.4 M | 32.9 M | 32.9 M | 32.9 M | 22.9 M | 39.9 M | 39.9 M | 39.9 M | -10.1 M | 6.53 M | 6.53 M | 6.53 M | 10.1 M | 13 M | 13 M | 13 M | 19.4 M | 20.1 M | 20.1 M | 20.1 M | 32.5 M | 32.5 M | 32.5 M | 32.5 M | 35.6 M | 35.6 M | 35.6 M | 35.6 M | 59.5 M | 59.5 M | 59.5 M | 59.5 M |
All numbers in USD currency